Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Oncogene|May 2, 1996
SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cellsS C Mok, W Y Chan, K K Wong, et al.
The Journal of Reproductive Medicine|March 1, 1994
Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitroM A Steller, S C Mok, J Yeh, et al.
Cancer Research|February 1, 1997
A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomasK H Lu, J N Weitzel, S Kodali, et al.
Cancer Research|May 15, 1995
Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumorsK J Rodabaugh, G Blanchard, W R Welch, et al.
Obstetrics and Gynecology|January 23, 1999
A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancerK H Lu, D W Cramer, M G Muto, et al.
Gynecologic Oncology|June 1, 2000
Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumorZ S Tuncer, G L Vegh, V Fulop, et al.
Molecular Carcinogenesis|September 6, 2000
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell linesC Rauh-Adelmann, K M Lau, N Sabeti, et al.
Gynecologic Oncology|October 20, 1999
Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placentaG L Vegh, Z Selcuk Tuncer, V Fulop, et al.
Oncogene|February 15, 1996
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancerJ Tangir, M G Muto, R S Berkowitz, et al.
Gynecologic Oncology|June 1, 2000
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumorsL W Huang, A P Garrett, D A Bell, et al.
Pageof 7